SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes audit at Dr. Reddy’s API Cuernavaca plant in Mexico

21 Jul 2017 Evaluate

US Food and Drug Administration (USFDA) has completed audit of Dr. Reddy’s Laboratories’ API Cuernavaca plant at Mexico with Zero observation.

Earlier, USFDA completed audit of the company’s Formulations Srikakulam Plant (SEZ) Unit I, Andhra Pradesh, on June 16, 2017. The pharma major had been issued a Form 483 with one observation, which it is addressing.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

 

Dr. Reddys Lab Share Price

1275.50 -17.75 (-1.37%)
11-May-2026 09:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1845.75
Dr. Reddys Lab 1275.50
Cipla 1333.75
Zydus Lifesciences 934.50
Lupin 2243.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×